Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and fiscal year ended March 31, 2026
Filing Date: May 12, 2026
This filing serves as a disclosure of results of operations and financial condition. The company announced its results under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS) via a press release and attached exhibits.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached exhibits (Exhibits 99.2, 99.3, 99.4, and 99.5) which are referenced but not included in the text body of this summary.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release and audited financial results for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The text confirms the issuance of a press release regarding Q4 FY2026 results but does not include the content of management commentary, future guidance, or specific risk factors within this document.
Unusual Items: No unusual items are described in the filing text itself.
Investor Verification Checklist
- Review Exhibit 99.2 (Press Release) for specific revenue and profit figures for Q4 and FY2026.
- Examine Exhibit 99.3 (IFRS Audited Consolidated Results) for standardized financial metrics.
- Check Exhibit 99.4 and 99.5 for Ind AS consolidated and standalone results to understand local regulatory reporting differences.
- Verify the Outcome of the Board Meeting (Exhibit 99.1) for dividend declarations or other corporate actions.
- Confirm the audit status of the financial statements as indicated in the exhibit descriptions.